Skip to content
healthcare.dev

Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate

NDC 0406-8020, Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate, tablet, from SpecGx LLC.

Product NDC
0406-8020
Status
Listed
Labeler
SpecGx LLC
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207000
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0406-8020 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
0406-8020-030040680200330 TABLET in 1 BOTTLE, PLASTIC (0406-8020-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/62abde41-46cb-4e90-a798-23d6531bf9aa
  • NADAC price for package 00406802003

    GET /v1/drugs/nadac/00406802003

Use it

Look up 0406-8020 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0406-8020 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0406-8020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.